2.9700
-0.0300
(-1.00%)
At close: April 17 at 4:00:02 PM EDT
2.9700
0.00
(0.00%)
After hours: April 17 at 4:01:54 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 3 | 3 |
| Avg. Estimate | -0.41 | -0.41 | -1.72 | -1.72 |
| Low Estimate | -0.42 | -0.42 | -1.76 | -1.78 |
| High Estimate | -0.4 | -0.41 | -1.64 | -1.59 |
| Year Ago EPS | -0.75 | -0.48 | -2 | -1.72 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | -- | -- | -- | 8.61M |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | 17.22M |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.61 | -0.77 | -0.43 | -0.29 |
| EPS Actual | -0.75 | -0.48 | -0.37 | -0.4 |
| Difference | -0.14 | 0.29 | 0.06 | -0.11 |
| Surprise % | -23.81% | 37.35% | 13.02% | -38.11% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.41 | -0.41 | -1.72 | -1.72 |
| 7 Days Ago | -0.37 | -0.38 | -1.69 | -1.73 |
| 30 Days Ago | -0.37 | -0.38 | -1.69 | -1.73 |
| 60 Days Ago | -0.37 | -0.38 | -1.58 | -1.59 |
| 90 Days Ago | -0.37 | -0.38 | -1.58 | -1.59 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | 1 |
| Up Last 30 Days | -- | -- | -- | 1 |
| Down Last 7 Days | 2 | 1 | 1 | 1 |
| Down Last 30 Days | 2 | 1 | 1 | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| AVIR | 45.23% | 13.67% | 14.21% | 0.03% |
| S&P 500 | 7.04% | 4.85% | 8.57% | 14.16% |
Upgrades & Downgrades
| Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 4/11/2025 |
| Upgrade | Morgan Stanley: Underweight to Equal-Weight | 8/13/2024 |
| Downgrade | JP Morgan: Neutral to Underweight | 8/10/2023 |
| Maintains | JP Morgan: Neutral | 3/16/2023 |
| Maintains | SVB Leerink: Market Perform | 1/27/2023 |
| Maintains | Morgan Stanley: Underweight | 1/24/2023 |
Related Tickers
COYA Coya Therapeutics, Inc.
5.26
+0.77%
EPIX ESSA Pharma Inc.
1.7900
+1.13%
SPRB Spruce Biosciences, Inc.
0.1187
-3.50%
RPTX Repare Therapeutics Inc.
1.2000
+4.35%
LVTX LAVA Therapeutics N.V.
1.3100
+6.50%
NXTC NextCure, Inc.
0.3612
+7.89%
KROS Keros Therapeutics, Inc.
14.07
+3.99%
THRD Third Harmonic Bio, Inc.
5.16
+0.58%
DSGN Design Therapeutics, Inc.
3.5000
+3.55%
DTIL Precision BioSciences, Inc.
5.02
+0.20%